GlaxoSmithKline PLC (NYSE:GSK)

40.33
Delayed Data
As of Apr 23
 +0.33 / +0.82%
Today’s Change
34.52
Today|||52-Week Range
44.54
+13.70%
Year-to-Date

Today’s Trading

Previous close40.00
Today’s open40.17
Day’s range40.14 - 40.35
Volume3,387,806
Average volume (3 months)4,127,044
Market cap$92.6B
Data as of 4:02pm ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)+59.84%
Earnings growth (this year)-1.45%
Earnings growth (next 5 years)+5.55%
Revenue growth (last year)+3.58%
P/E ratio46.7
Price/Sales2.25
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.27-0.53%
NVONovo Nordisk-0.21-0.45%
LLYEli Lilly and Co+1.14+1.44%
CELGCelgene+0.53+0.60%
Data as of 9:10am ET, 04/24/2018

Financials

Next reporting dateApril 25, 2018
EPS forecast (this quarter)$0.69
Annual revenue (last year)$38.9B
Annual profit (last year)$2.0B
Net profit margin5.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts